期刊文献+

丙泊酚输注综合征1例分析 被引量:3

Analysis of one case of propofol infusion syndrome
下载PDF
导出
摘要 目的探讨丙泊酚输注综合征的早期识别。方法分析发生于我院的1例丙泊酚输注综合征病例,探讨丙泊酚输注综合征的临床表现和特点。结果患者使用丙泊酚后出现了代谢性酸中毒、心电图改变、横纹肌溶解伴急性肾损伤、转氨酶及乳酸升高等临床症状,考虑为丙泊酚输注综合征。结论丙泊酚输注综合征为严重的药源性疾病,疾病死亡率高。如患者在使用丙泊酚时出现代谢性酸中毒、横纹肌溶解、ECG改变中的一种或多种症状需警惕。用药期间监测血酸碱度、乳酸、肌酸激酶和心电图是早期识别疾病的关键。 Objective To research the early diagnosis of propofol infusion syndrome.Methods To study the symptoms of propofol infusion syndrome by analyzing a patient who was diagnosed with propofol infusion syndrome.Results After propofol was administered,the patient had metabolic acidosis,ECG changes,rhabdomyolysis with acute kidney injury and elevated transaminase and lactate.The patient was diagnosed with propofol infusion syndrome.Conclusion Propofol infusion syndrome is a severe drug-induced disease with high mortality.Clinicians should consider propofol infusion syndrome in case of one or more symptoms of metabolic acidosis,ECG changes and rhabdomyolysis.To monitor pH,creatine kinase,lactate and ECG is the key to the early diagnosis of propofol infusion syndrome.
作者 林志豪 姚慧娟 陆晓彤 张健 LIN Zhi-hao;YAO Hui-juan;LU Xiao-tong;ZHANG Jian(Department of Pharmacy,Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China;Department of Pharmacy,Dongguan Kanghua Hospital,Dongguan 523080,China)
出处 《实用药物与临床》 CAS 2021年第9期861-864,共4页 Practical Pharmacy and Clinical Remedies
关键词 丙泊酚 丙泊酚输注综合征 药物不良反应 横纹肌溶解 Propofol Propofol infusion syndrome Adverse drug reaction Rhabdomyolysis
  • 相关文献

参考文献4

二级参考文献23

  • 1Schroeppel TJ, Fabian TC, Clement LP, et al.Propofol infu- sion syndrome: a lethal condition in critically injured patients eliminated by a simple screening protocol. Injury, 2014, 45 (1) : 245-249.
  • 2Diaz JH, Prabhakar A, Urman RD, et al. Propofol infusion syndrome: a retrospective analysis at a level 1 trauma center. Crit Care Res Pract, 2014,54(3):62-68.
  • 3Mayette M, Gonda J, Hsu JL, et al. Propofol infusion syndrome resuscitation with extracorporeal life support; a case report and review of the literature.Ann Intensive Care, 2013,3 ( 1 ) 32.
  • 4Vanlander AV. Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. Acta Anaesthesiol Scand, 2012,56(4) : 520-525.
  • 5Mtaweh H, Bayir H, Kochanek PM, et al. Efect of a single dose of propofol and lack of dextrose administration in a child with mitochondrial disease: a case report. J Child Neurol, 2014,29(8) .. NP40-46.
  • 6Kajimoto M, Atkinson DB, Ledee DR, et al. Propofol compared with isoiqurane inhibits mitochondrial metabolism in immature swine cerebral cortex. J Cerebral Blood Flow Metab, 2014,34(3) 514-521.
  • 7Amrein S, Amrein K, Amegah-Sakotnik A, et al. PropoIol in- fusion syndrome--a critical incident report highlighting the danger of reexposure. J Neurosurg Anesthesiol, 2011, 23 (3) : 265-266.
  • 8Ramaiah R,Lollo L, Brannan D, et al. Propofol infusion syn- drome in a super morbidly obese patient (BMI= 75). Int J Crit Illn Inj Sci, 2011, 1(1):84-86.
  • 9Imam TH. Propofol-related infusion syndrome role of propofol in medical complications of sedated critical care pa- tients. Penn J, 2013, 17 (2) : 85-87.
  • 10Diedrich DA,Brown DR. Analytic reviews propofol infusion syn- drome in the ICU. J Intensive Care Me, 2011, 26(2) :59-72.

共引文献25

同被引文献53

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部